Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

141516171819202122

AstraZeneca has healthy pipeline but margin clarity "may be needed"

27th Nov 2023 15:09

(Alliance News) - AstraZeneca PLC may need to offer some margin certainty for its shares to push higher, despite it having a decent top-line growth outlook, investment bank Jefferies said. Read More

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

27th Nov 2023 09:20

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

23rd Nov 2023 18:41

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752. Read More

AstraZeneca launches new life sciences tech innovation firm Evinova

20th Nov 2023 10:49

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes. Read More

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

17th Nov 2023 12:00

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures. Read More

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

17th Nov 2023 09:03

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK. Read More

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

17th Nov 2023 08:31

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer. Read More

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

17th Nov 2023 07:58

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell. Read More

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

14th Nov 2023 10:51

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint. Read More

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

13th Nov 2023 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning: Read More

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

9th Nov 2023 12:06

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data. Read More

Lancashire Holdings declares special dividend after strong year so far

9th Nov 2023 11:02

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date. Read More

AstraZeneca turns up heat in Nordisk-dominated weight loss drug space

9th Nov 2023 10:10

(Alliance News) - AstraZeneca PLC on Thursday said it struck a licence deal in the weight loss drug space, giving something to think about for Novo Nordisk AS, whose Ozempic and Wegovy products have laid down the gauntlet for the rest of the pharma space. Read More

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

9th Nov 2023 09:23

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu. Read More

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

9th Nov 2023 08:57

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade. Read More

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

9th Nov 2023 07:48

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood. Read More

AstraZeneca plans next phase of trial on kidney drug combination data

3rd Nov 2023 17:06

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria. Read More

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

3rd Nov 2023 11:34

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy. Read More

UK earnings, trading statements calendar - next 7 days

2nd Nov 2023 15:57

Read More

AstraZeneca launches collaboration and investment deal with Cellectis

1st Nov 2023 08:59

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis. Read More

141516171819202122
FTSE 100 Latest
Value8,275.66
Change0.00